Top Four - home page

The Exeter has appointed Michael Payne as chief financial officer (CFO). He succeeds John Gunn who is retiring. Payne joined The Exeter as commercial director in October last year and has more...

Pivotal Growth has acquired mortgage and protection broker Morrison Ward Associates (MWA) for an undisclosed sum. Operating out of London and targeting a mid-to-high net worth customer base, MWA was founded in...

Group private medical insurance (PMI) premiums are rising at such a level that some employers are considering ending cover entirely. But these companies are in a very small minority as the vast...

Legal & General has appointed Nicki Plews as head of product and proposition for retail protection. Plews joins Legal & General from Munich Re, where she was business development director responsible for...

National Friendly has launched Friendly Shield which provides essential, non-underwritten cover for unforeseen eventualities. The provider said Friendly Shield is designed in response to adviser feedback to support stretched household finances from...

Axa Hong Kong and Macau has launched CareForAll Hospital Cash Plan which gives customers a  daily hospital cash benefit and is accessed via a relaxed underwriting process.  The plan aims to ensure...

Mortgage and protection network New Leaf Distribution has promoted Daniel Hobbs from managing director to CEO, subject to regulatory approval. Current investment director, Sam Wallis will succeed Daniel Hobbs in the role...

Breast cancer was the most common cancer type affecting Vitality's female health claimants in 2023. For men it was skin and prostate cancer. The insurer's claims data shows breast cancer made up...

  The claims journey should be a hero journey bringing together supportive human interaction with technology interventions to smooth the process, says Scott Cadger, head of claims and underwriting strategy at Scottish...

Although ultra high net worth individuals (UHNWIs) can afford to self-fund their medical expenses, international private medical insurance (IPMI) should still be considered as a worthwhile investment, especially with the costs of...